Adell Harriman & Carpenter’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.92M Sell
32,406
-146
-0.4% -$34K 0.48% 47
2025
Q4
$6.74M Buy
32,552
+887
+3% +$175K 0.4% 48
2025
Q3
$5.87M Sell
31,665
-1,114
-3% -$191K 0.36% 55
2025
Q2
$5.01M Sell
32,779
-5,487
-14% -$843K 0.33% 59
2025
Q1
$6.35M Sell
38,266
-678
-2% -$106K 0.48% 51
2024
Q4
$5.63M Sell
38,944
-3,953
-9% -$613K 0.39% 53
2024
Q3
$6.95M Sell
42,897
-4,784
-10% -$762K 0.51% 50
2024
Q2
$6.97M Sell
47,681
-27,454
-37% -$4.08M 0.54% 46
2024
Q1
$11.9M Sell
75,135
-4,994
-6% -$795K 0.98% 29
2023
Q4
$12.6M Sell
80,129
-7,162
-8% -$1.1M 1.16% 26
2023
Q3
$13.6M Sell
87,291
-1,281
-1% -$211K 1.41% 21
2023
Q2
$14.5M Sell
88,572
-3,392
-4% -$547K 1.47% 19
2023
Q1
$14.3M Sell
91,964
-2,164
-2% -$349K 1.53% 18
2022
Q4
$16.6M Buy
94,128
+714
+0.8% +$123K 1.91% 11
2022
Q3
$15.3M Buy
93,414
+5,039
+6% +$853K 1.86% 14
2022
Q2
$15.7M Buy
88,375
+330
+0.4% +$58.8K 1.92% 13
2022
Q1
$15.6M Sell
88,045
-1,721
-2% -$293K 1.52% 20
2021
Q4
$15.4M Buy
89,766
+4,419
+5% +$723K 1.42% 23
2021
Q3
$13.8M Sell
85,347
-80
-0.1% -$13.6K 1.44% 19
2021
Q2
$14.1M Buy
85,427
+1,415
+2% +$234K 1.48% 17
2021
Q1
$13.8M Buy
84,012
+3,804
+5% +$616K 1.67% 12
2020
Q4
$12.6M Buy
80,208
+810
+1% +$120K 1.66% 16
2020
Q3
$11.8M Buy
79,398
+6,643
+9% +$983K 1.76% 14
2020
Q2
$10.2M Buy
72,755
+10,525
+17% +$1.53M 1.75% 13
2020
Q1
$8.16M Sell
62,230
-6,435
-9% -$913K 1.73% 13
2019
Q4
$10M Sell
68,665
-1,359
-2% -$184K 1.65% 18
2019
Q3
$9.06M Sell
70,024
-7,539
-10% -$993K 1.64% 19
2019
Q2
$10.8M Buy
77,563
+502
+0.7% +$69.5K 2.02% 14
2019
Q1
$10.8M Sell
77,061
-4,283
-5% -$574K 2.1% 12
2018
Q4
$10.5M Buy
81,344
+1,643
+2% +$229K 2.31% 8
2018
Q3
$11M Sell
79,701
-246
-0.3% -$32.7K 2.06% 13
2018
Q2
$9.7M Sell
79,947
-289
-0.4% -$36.1K 1.92% 15
2018
Q1
$10.3M Buy
80,236
+1,847
+2% +$250K 2.13% 11
2017
Q4
$11M Buy
78,389
+421
+0.5% +$58.6K 2.32% 9
2017
Q3
$10.1M Sell
77,968
-939
-1% -$124K 2.21% 11
2017
Q2
$10.4M Sell
78,907
-1,560
-2% -$199K 2.36% 7
2017
Q1
$10M Sell
80,467
-1,056
-1% -$126K 2.3% 8
2016
Q4
$9.39M Buy
81,523
+915
+1% +$106K 2.34% 7
2016
Q3
$9.52M Sell
80,608
-2,039
-2% -$247K 2.41% 6
2016
Q2
$10M Sell
82,647
-1,271
-2% -$144K 2.62% 5
2016
Q1
$9.08M Buy
83,918
+4,292
+5% +$444K 2.44% 6
2015
Q4
$8.18M Buy
79,626
+2,480
+3% +$249K 2.2% 8
2015
Q3
$7.2M Buy
77,146
+1,948
+3% +$188K 2.11% 9
2015
Q2
$7.33M Buy
75,198
+530
+0.7% +$53.1K 1.89% 10
2015
Q1
$7.51M Buy
74,668
+3,102
+4% +$315K 1.98% 8
2014
Q4
$7.48M Buy
71,566
+1,128
+2% +$119K 2.04% 7
2014
Q3
$7.37M Hold
70,438
2.03% 9
2014
Q2
$7.37M Sell
70,438
-3,377
-5% -$341K 2.03% 9
2014
Q1
$7.25M Buy
73,815
+60
+0.1% +$5.56K 2.14% 7
2013
Q4
$6.76M Sell
73,755
-231
-0.3% -$21.3K 2.1% 7
2013
Q3
$6.41M Sell
73,986
-1,492
-2% -$134K 1.81% 9
2013
Q2
$6.48M Buy
+75,478
New +$6.41M 2.32% 6

Other funds holding JNJ

Adell Harriman & Carpenter's JNJ Position: Q1 2026 in Review

Adell Harriman & Carpenter reduced its Johnson & Johnson (JNJ) stake by 0.45% in Q1 2026, selling an estimated $34K and leaving 32,406 shares worth $7.92M. The position accounts for 0.48% of the portfolio, ranked #47.

Adell Harriman & Carpenter first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.6M in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Adell Harriman & Carpenter held 32,406 shares of Johnson & Johnson worth $7.92M as of Q1 2026.
  • Adell Harriman & Carpenter sold 146 Johnson & Johnson shares in Q1 2026, an estimated $34K.
  • Johnson & Johnson made up 0.48% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #47 holding.
  • Adell Harriman & Carpenter first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Adell Harriman & Carpenter's Johnson & Johnson position peaked at $16.6M in Q4 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.